cannabinoids
28stories
cannabinoids · page 3
- Pharmaceutical
Agreements to advance chronic pain relief for trigeminal neuralgia
Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
- Pharmaceutical
Exclusive derivative library licence for Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
- CBD Market
Understanding the CDC warning about Delta-8
The Centers for Disease Control (CDC) and the Food and Drug Administration have issued official health warnings to Americans who are considering or already use Delta-8, a cannabinoid derived from hemp, reports Fast Company.
- Uncategorized
Understanding biosynthesis in the cannabis sector
On this episode of BofC Live, we connect with Dr. Mather Carscallen, the CEO and CTO of Algae-C – a plant biosynthesis company using algae to create plant-derived active pharmaceutical ingredients (APIs) – including cannabinoids.
